Amarin Corp Plc (AMRN)

[everyonesguess]

European advisory group rescinds authorization for omega-3 fatty acid meds for use after heart attacks

Dec. 14, 2018 12:09 PM ET|By: Douglas W. House, SA News Editor

•Citing the lack of evidence that they work for the indication, the European Medicines Agency's advisory group CHMP has withdrawn its authorization for the use of omega-3 fatty acid medications to prevent further heart and blood vessel problems in heart attack patients. The meds have been approved in the EU since 2000 at a dose of 1g/day for this indication.

•The medications remain approved for reducing triglyceride levels.

•Related tickers: (AMRN -1.9%)(MTNB +0.6%)(NEPT -0.7%)

Read it carefully: The meds have been approved in the EU since 2000 at a dose of 1g/day for this indication

So this is not about V (approved 2013 in US and not yet in EU.

Some MM just take it to slump AMRN PPS down!!!!

The dark before dawn.